A rifaximin klinikai és farmakológiai jellemzoi, nem felszívódó antibiotikum az intestinalis megbetegedések kezelésére.

Translated title of the contribution: Clinical and pharmacological aspects of rifaximin, local antibiotic therapy in intestinal disorders

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

The authors report pharmacokinetics and indications of rifaximin and the results of clinical studies. Rifaximin has a large antibacterial spectrum with a good therapeutic effect on both gram positive and gram negative aerob and anaerob bacteria. Practically there is no absorption (< 1%) following oral administration with a high concentration in gastrointestinal mucosa (8000 microg/g). No increase in absorption can be detected in intestinal damage caused by inflammatory bowel disease. The remarkable safety profile of rifaximin is due to its negligible quality of absorption. According to the clinical studies rifaximin could be an adequate therapeutic approach in all gastrointestinal diseases and interventions when antibacterial therapy is needed.

Translated title of the contributionClinical and pharmacological aspects of rifaximin, local antibiotic therapy in intestinal disorders
Original languageHungarian
Pages (from-to)2177-2181
Number of pages5
JournalOrvosi hetilap
Volume145
Issue number43
Publication statusPublished - Oct 24 2004

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Clinical and pharmacological aspects of rifaximin, local antibiotic therapy in intestinal disorders'. Together they form a unique fingerprint.

  • Cite this